Annual EBIT
-$81.41 M
-$28.17 M-52.92%
December 31, 2023
Summary
- As of March 13, 2025, AVTE annual earnings before interest & taxes is -$81.41 million, with the most recent change of -$28.17 million (-52.92%) on December 31, 2023.
- During the last 3 years, AVTE annual EBIT has fallen by -$72.52 million (-815.84%).
- AVTE annual EBIT is now -2344.71% below its all-time high of -$3.33 million, reached on December 31, 2019.
Performance
AVTE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$17.41 M
+$8.76 M+33.46%
September 30, 2024
Summary
- As of March 13, 2025, AVTE quarterly earnings before interest & taxes is -$17.41 million, with the most recent change of +$8.76 million (+33.46%) on September 30, 2024.
- Over the past year, AVTE quarterly EBIT has increased by +$4.66 million (+21.10%).
- AVTE quarterly EBIT is now -1145.35% below its all-time high of -$1.40 million, reached on March 1, 2020.
Performance
AVTE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$90.26 M
+$3.96 M+4.20%
September 30, 2024
Summary
- As of March 13, 2025, AVTE TTM earnings before interest & taxes is -$90.26 million, with the most recent change of +$3.96 million (+4.20%) on September 30, 2024.
- Over the past year, AVTE TTM EBIT has dropped by -$8.85 million (-10.87%).
- AVTE TTM EBIT is now -6356.29% below its all-time high of -$1.40 million, reached on March 1, 2020.
Performance
AVTE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AVTE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.9% | +21.1% | -10.9% |
| 3 y3 years | -815.8% | +21.1% | -10.9% |
| 5 y5 years | -2344.7% | +21.1% | -10.9% |
AVTE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -253.6% | at low | -110.6% | +33.5% | -292.1% | +4.2% |
| 5 y | 5-year | -2344.7% | at low | -1145.3% | +33.5% | -6356.3% | +4.2% |
| alltime | all time | -2344.7% | at low | -1145.3% | +33.5% | -6356.3% | +4.2% |
Aerovate Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.41 M(-33.5%) | -$90.26 M(-4.2%) |
| Jun 2024 | - | -$26.16 M(+6.3%) | -$94.22 M(+6.6%) |
| Mar 2024 | - | -$24.62 M(+11.6%) | -$88.39 M(+8.6%) |
| Dec 2023 | -$81.41 M(+52.9%) | -$22.07 M(+3.3%) | -$81.41 M(+8.3%) |
| Sep 2023 | - | -$21.37 M(+5.1%) | -$75.19 M(+10.6%) |
| Jun 2023 | - | -$20.34 M(+15.3%) | -$67.98 M(+13.6%) |
| Mar 2023 | - | -$17.64 M(+11.3%) | -$59.86 M(+12.4%) |
| Dec 2022 | -$53.24 M | -$15.85 M(+12.0%) | -$53.24 M(+16.6%) |
| Sep 2022 | - | -$14.15 M(+15.9%) | -$45.65 M(+21.1%) |
| Jun 2022 | - | -$12.21 M(+10.9%) | -$37.70 M(+20.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.02 M(+33.3%) | -$31.26 M(+35.8%) |
| Dec 2021 | -$23.02 M(+159.0%) | -$8.27 M(+33.4%) | -$23.02 M(+25.0%) |
| Sep 2021 | - | -$6.20 M(+7.4%) | -$18.42 M(+27.4%) |
| Jun 2021 | - | -$5.77 M(+107.7%) | -$14.46 M(+40.2%) |
| Mar 2021 | - | -$2.78 M(-24.1%) | -$10.31 M(+15.5%) |
| Dec 2020 | -$8.89 M(+166.9%) | -$3.66 M(+63.3%) | -$8.93 M(+69.6%) |
| Sep 2020 | - | -$2.24 M(+38.0%) | -$5.27 M(+74.2%) |
| Jun 2020 | - | -$1.63 M(+16.2%) | -$3.02 M(+116.2%) |
| Mar 2020 | - | -$1.40 M | -$1.40 M |
| Dec 2019 | -$3.33 M | - | - |
FAQ
- What is Aerovate Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual EBIT year-on-year change?
- What is Aerovate Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly EBIT year-on-year change?
- What is Aerovate Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aerovate Therapeutics?
- What is Aerovate Therapeutics TTM EBIT year-on-year change?
What is Aerovate Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AVTE is -$81.41 M
What is the all time high annual EBIT for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual earnings before interest & taxes is -$3.33 M
What is Aerovate Therapeutics annual EBIT year-on-year change?
Over the past year, AVTE annual earnings before interest & taxes has changed by -$28.17 M (-52.92%)
What is Aerovate Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AVTE is -$17.41 M
What is the all time high quarterly EBIT for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly earnings before interest & taxes is -$1.40 M
What is Aerovate Therapeutics quarterly EBIT year-on-year change?
Over the past year, AVTE quarterly earnings before interest & taxes has changed by +$4.66 M (+21.10%)
What is Aerovate Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AVTE is -$90.26 M
What is the all time high TTM EBIT for Aerovate Therapeutics?
Aerovate Therapeutics all-time high TTM earnings before interest & taxes is -$1.40 M
What is Aerovate Therapeutics TTM EBIT year-on-year change?
Over the past year, AVTE TTM earnings before interest & taxes has changed by -$8.85 M (-10.87%)